Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celgene-CELG -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (371)	11/5/1999 10:19:00 AM
From: Mike K	Read Replies (3) \| Respond to of 804

Peter; I agree with you however the side effects are horrendous. As a myeloma patient who's been using thalidomide since early September I've started to see some positive results on my counts. I've also suffered just about every side effect that's listed in Celgene's safety data. I'm sure many people who don't have cancer may take the view that a few side effects are worth it if the disease is cured. At this point no researcher including Barlogie is talking cure. I don't think that thalidomide will be the magic bullet. It will be used to delay the start of chemotherapy as is the case with me. It will also be used for refractory patients. For the cancer patient managing side effects becomes a quality of life issue. It's still significant to see how effective this drug has been. Cheers, Mike